$4.8M
MTech led the oversubscribed financing round, with participation from Project A Ventures and several other backers.
"The third thing that insurers are really interested in is prevention and also customer retention,"
Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 16 October 2026.
Announcements
1,485
Total raised
£42.6B
disclosed amounts
This month
£55.3M
raised so far
MTech led the oversubscribed financing round, with participation from Project A Ventures and several other backers.
"The third thing that insurers are really interested in is prevention and also customer retention,"
The capital will fund the ongoing development of the startup, which combines artificial intelligence matching with immersive virtual viewings.
"The VenueVerse is addressing a clear gap in a large, established market with a product that combines AI, immersive technology and deep sector insight. Stacey and Mark bring the first-hand experience, commercial understanding and determination we look for in founders. As greater choice reshapes the wedding landscape, we believe there is a compelling opportunity to improve how couples discover venues and how venues connect with the right customers."
The funding round was led by Backed, Lunar Ventures, Seraphim Space, MMC Ventures, and SOSV.
"I left my PhD because I was frustrated with the rate of progress in fusion energy. I wanted to take the strongest machine learning researchers in the world and apply them to these problems that really mattered, and a startup was the best way to do that,"
Andreessen Horowitz and Bessemer Venture Partners led the financing, which values the company at $4bn.
"The industries where AI matters most are still not the ones getting the most attention. Housing has enormous problems to solve, and we've grown by going deeper with our customers until we've solved the root causes. Every year, our customers trust us with more of their operations, and that kind of trust is earned only by a company built to last. Andreessen Horowitz and Bessemer Venture Partners understand that, and they're the partners we want for the long term"
The financing values the biotechnology company at $800m and will support its in vivo cell therapy pipeline.
"We believe the future of medicine lies in reprogramming the body to repair itsel. We design the models and the medicines to teach it howf"